Discussion
An experimental oral therapy called ifetroban proved generally safe and was well tolerated in adults with systemic sclerosis (SSc) over one year of treatment, according to top-line findings from a Phase 2a clinical trial. The trial, called ASSIST-SSc study (NCT02682511), compared once-daily ifetroban against a placebo in 41…